After Michael Thompson was diagnosed with brain cancer, doctors at Dana-Farber Cancer Institute gave him a choice.
He was given the option of undergoing a new, experimental form of chemotherapy — one that was not yet FDA-approved and had been tested on just one person before. Thompson was hesitant at first, but he ultimately decided to go through with the treatment.
That decision ended up saving his life. Though he was given just a five-percent chance of survival upon his diagnosis, Thompson is alive and well six years later.
Check out the video above to hear his story.